Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia

被引:1
|
作者
Schlenz, Alyssa M. [1 ]
Phillips, Shannon M. [2 ]
Mueller, Martina [2 ,3 ]
Melvin, Cathy L. [3 ]
Adams, Robert J. [4 ]
Kanter, Julie [5 ]
机构
[1] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA
[2] Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA
[4] Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA
[5] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
来源
关键词
transfusion; sickle cell anemia; qualitative; multilevel ecological model; HEMATOLOGY; 2020; GUIDELINES; AMERICAN SOCIETY; DISEASE; PREVENTION; MANAGEMENT; CHILDREN; CARE;
D O I
10.1177/27527530211073874
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Chronic red cell transfusion (CRCT) therapy is one of a few effective disease-modifying therapies for children with sickle cell anemia (SCA). CRCT is recommended for primary and secondary stroke prevention for at-risk children with SCA and is sometimes used for other disease-related complications. However, CRCT can be resource- and time-intensive for patients/families, providers, and organizations. This study was conducted to provide a comprehensive, multilevel examination of barriers and facilitators to transfusion therapy in children with SCA from health care provider and caregiver perspectives. Methods: A qualitative descriptive approach was used to conduct key informant interviews in a sample of 26 caregivers and 25 providers across the United States. Interviews were analyzed using directed content analysis with the Multilevel Ecological Model of Health as an initial coding framework and the constant comparison method. Results: Ten barrier themes and 10 facilitator themes emerged across all ecological levels. Themes most commonly occurred on the patient and organizational levels. Key barriers themes included Logistical Challenges, Obtaining and Maintaining Venous Access, Alloantibodies/Alloimmunization and Reactions, and Iron Overload and Adherence to Chelation Therapy. Key facilitator themes included Nursing and Non-nursing Staff Support, Positive Child/Family Experiences, Logistical Help and Social Resources, Blood Bank and Access to Blood, and Transfusion-Specific Resources. Discussion: The comprehensive understanding of multilevel barriers and facilitators to transfusion therapy, including the role of nursing, in children with SCA can inform strategies to improve CRCT for patients/families and providers and can also be applied by organizations seeking to implement transfusion services for SCA.
引用
收藏
页码:209 / 220
页数:12
相关论文
共 50 条
  • [21] Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea
    Lebensburger, Jeffrey D.
    Sidonio, Robert F.
    DeBaun, Michael R.
    Safford, Monika M.
    Howard, Thomas H.
    Scarinci, Isabel C.
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 (08) : 1333 - 1337
  • [22] CARDIOVASCULAR-RESPONSE TO CHRONIC TRANSFUSION IN SICKLE-CELL-ANEMIA
    GAFFNEY, JW
    BIERMAN, FZ
    DONNELLY, CM
    SUTTON, M
    PIOMELLI, S
    [J]. CIRCULATION, 1986, 74 (04) : 336 - 336
  • [23] Comparison of Chronic Transfusion Volume Protocols for Children with Sickle Cell Anemia
    Rollins, Margo
    Yee, Marianne McPherson
    Josephson, Cassandra
    Fasano, Ross
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S20 - S20
  • [24] Red blood cell transfusion in pediatric patients with severe chronic anemia: How slow is necessary?
    Agrawal, Anurag K.
    Hsu, Edmund
    Quirolo, Keith
    Neumayr, Lynne D.
    Flori, Heidi R.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 58 (03) : 466 - 468
  • [25] Effects of red blood cell transfusion on resting energy expenditure in adolescents with sickle cell anemia
    Harmatz, P
    Heyman, MB
    Cunningham, J
    Lee, PDK
    Styles, L
    Quirolo, K
    Kopp-Hoolihan, F
    Ghiron, J
    Hintz, RL
    Vichinsky, E
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 29 (02): : 127 - 131
  • [26] Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy
    Harmatz, P
    Butensky, E
    Quirolo, K
    Williams, R
    Ferrell, L
    Moyer, T
    Golden, D
    Neumayr, L
    Vichinsky, E
    [J]. BLOOD, 2000, 96 (01) : 76 - 79
  • [27] INTENSIVE TRANSFUSION THERAPY FOR PRIAPISM IN BOYS WITH SICKLE-CELL ANEMIA
    SEELER, RA
    [J]. JOURNAL OF UROLOGY, 1973, 110 (03): : 360 - 361
  • [28] HYDROXYUREA - AN ALTERNATIVE TO TRANSFUSION THERAPY FOR STROKE IN SICKLE-CELL-ANEMIA
    WARE, RE
    STEINBERG, MH
    KINNEY, TR
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (02) : 140 - 143
  • [29] TRANSFUSION THERAPY IN BETA-THALASSEMIA AND SICKLE-CELL-ANEMIA
    POLITIS, S
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1992, 37 (01): : 6 - 12
  • [30] The use of rejuvenated red blood cells for transfusion in patients with sickle cell anemia
    Webb, Jennifer
    [J]. TRANSFUSION, 2019, 59 (10) : 3042 - 3045